Clinical trial
Clofarabine in Adult Patients With Advanced Solid Tumors
NCT00125840 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00125840 |
|---|---|
| Title | Clofarabine in Adult Patients With Advanced Solid Tumors |
| Official title | A Phase I and Pharmacokinetic Study of Clofarabine in Adult Patients With Advanced Solid Tumors |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Tumors, Leukemia, Lymphocytic, Acute, Pediatric, Adult, Myelocytic, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | clofarabine (IV formulation) |
| Start date | Aug 1, 2002 |
| Completion | Aug 1, 2007 |
| First posted | Aug 2, 2005 |
| Last update posted | Feb 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: